Arthritis Research UK is the leading UK funder of research into the cause, treatment and cure of arthritis. It is the UK’s fourth largest medical research charity and the only charity solely committed to funding high quality research into arthritis.
CaSE welcomes new member Arthritis Research UK
18 Aug 2015
Dr Liam O’Toole, chief executive officer of Arthritis Research UK comments on their decision to join CaSE:
“We are delighted to become a member of CaSE and look forward to working with them to champion the importance of science and engineering in the UK. Alongside CaSE, Arthritis Research UK is committed to ensuring that the UK continues to be a world leader in science and research.
Around 10 million people in the UK live with the pain of arthritis. As a charity, we are focussed on stopping the devastating impact arthritis has on people’s lives, preventing the onset of arthritis and developing a cure. We want to enable people with arthritis to be able to say ‘I am in control, independent and recognised’. A thriving scientific community and research environment is vital in enabling us to make a difference. We want to ensure that the research community is fully supported in the long-term to conduct ground-breaking work with the ultimate goal of finding a cure for arthritis and musculoskeletal conditions.”
Naomi Weir, CaSE Acting Director said:
“It is wonderful to welcome Arthritis Research UK as a member of CaSE. The UK research community consists of an interconnected network of charities and academic institutions as well as public bodies and private companies. We are pleased to be representing the diverse mix of organisations that together strengthen the UK’s position as a leading scientific nation.
We look forward to working with Arthritis Research UK to ensure the government takes action to support a thriving science and engineering sector in the UK in years to come.”
CaSE are keen to ensure the needs of the whole science and engineering community are being heard at the highest levels of government.
Related press
Today the Campaign for Science and Engineering (CaSE) has published its 2023-24 Annual Review.
The Campaign for Science and Engineering (CaSE) is delighted to welcome the Cell and Gene Therapy (CGT) Catapult into its membership.
The Campaign for Science and Engineering (CaSE) is thrilled to welcome UCB into its membership.
CaSE is pleased to welcome Elsevier into its membership. Elsevier have supported CaSE’s work for many years, and we are delighted they have joined us as members.